BMC Research Notes (Sep 2020)

Laparoscopic sleeve gastrectomy in obese patients with ventricular assist devices: a data note

  • Adrian daSilva-deAbreu,
  • Kiran Garikapati,
  • Bader Aldeen Alhafez,
  • Sapna Desai,
  • Clement Eiswirth,
  • Selim Krim,
  • Hamang Patel,
  • Carl J. Lavie,
  • Hector O. Ventura,
  • Juan Francisco Loro-Ferrer,
  • Stacy A. Mandras

DOI
https://doi.org/10.1186/s13104-020-05272-2
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 3

Abstract

Read online

Abstract Objectives Patients with end-stage heart failure (ESHF) treated with ventricular assist devices (VADs) tend to gain weight after implantation, which is associated with higher complication rates and is a contraindication for heart transplantation (HT). The objective was to analyze the outcomes of obese patients with ESHF and VADs who underwent laparoscopic sleeve gastrectomy (LSG) at Ochsner Medical Center in New Orleans, which is the only program performing VADs and HT in the State of Louisiana, and also one of the largest VAD centers in the USA. Data description This dataset contains detailed baseline, perioperative, and long-term data of patients with VADs undergoing LSG. These variables were collected retrospectively from electronic medical records. Patients who achieved ≥ 50% excess BMI loss, BMI ≤ 35 kg/m2, listing for HT, HT, or myocardial recovery were identified and the timing to each of these milestones was documented. These data can be used alone or in combination with other datasets to achieve a larger sample size with more power for further analysis of these variables, which include the most important, standard, and objective bariatric and ESHF outcomes of patients with VADs undergoing LSG. Elaboration of composite outcomes is feasible.

Keywords